Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis.

J Am Heart Assoc · 2024 · PMC11056170 · PMID 38293935

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

The multiplicative interaction between aspirin use and lipoprotein(a) level for CHD events was borderline significant with a P value of 0.08.

also in 11,409 other papers

a nonsignificant trendno p-value reported

There was a nonsignificant trend towards greater risk of CHD events with aspirin use in unadjusted models with lipoprotein(a) ≤50 mg/dL (HR, 1.26 [95% CI, 0.99–1.61]) and lipoprotein(a) >50 mg/dL (HR, 1.38 [95% CI, 0.91–2.09]).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.